Role of Epoxide Hydrolases and Cytochrome P450s on Metabolism of KZR-616, a First-in-Class Selective Inhibitor of the Immunoproteasome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of Epoxide Hydrolases and Cytochrome P450s on Metabolism of KZR-616, a First-in-Class Selective Inhibitor of the Immunoproteasome

Published:2021-07-07 Issue:9 Volume:49 Page:810-821
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Fang Ying,Johnson Henry,Anderl Janet L.,Muchamuel Tony,McMinn Dustin,Morisseau Christophe,Hammock Bruce D.,Kirk Christopher,Wang Jinhai

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference48 articles.

1. Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events

2. Immunoproteasome-Specific Inhibitors and Their Application

3. The immunoproteasome: a novel drug target for autoimmune diseases;Basler;Clin Exp Rheumatol,2015

4. Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

5. Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-04-18

2. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors;Cell Communication and Signaling;2024-02-08

3. Quantum Mechanics Modeling of Oxetanes as Epoxide Hydrolase Substrates;Letters in Drug Design & Discovery;2023-09

4. Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline;Drugs;2023-03-27

5. Targeting immunoproteasome in neurodegeneration: A glance to the future;Pharmacology & Therapeutics;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3